FBRX

NASDAQ · Biotechnology

Forte Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$26.37

+0.65 (+2.53%)

As of Mar 25, 3:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -69.8% upside

Low Target $5.39

Average Target $7.97

High Target $9.61

Current Price $26.37

Current
$26.37

Target
$7.97

$5.39 $7.97 avg $9.61

Scenario Analysis

Bear Case

$5.39

-79.6%

Low target

Base Case

$7.97

-69.8%

Avg target

Bull Case

$9.61

+-63.6%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$35.62

-26.0% from high

52-Week Low

$4.90

+438.2% from low

Target vs 52W High

$7.97

-77.6% vs high

Next Earnings Report

Mar 26, 2026 · After Market Close

Today

EPS Est: $-1.24

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%